Detalhe da pesquisa
1.
Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS).
BMC Cancer
; 22(1): 725, 2022 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780096
2.
N terminus of ASPP2 binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence.
Proc Natl Acad Sci U S A
; 110(1): 312-7, 2013 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23248303
3.
Evaluation of apoptosis stimulating protein of TP53-1 (ASPP1/PPP1R13B) to predict therapy resistance and overall survival in acute myeloid leukemia (AML).
Cell Death Dis
; 15(1): 25, 2024 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38195541
4.
ASPP2κ Is Expressed In Human Colorectal Carcinoma And Promotes Chemotherapy Resistance And Tumorigenesis.
Front Mol Biosci
; 8: 727203, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34805267
5.
A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer.
Anticancer Res
; 39(1): 245-252, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30591465
6.
Dasatinib overrides the differentiation blockage in a patient with mutant-KIT D816V positive CBFß-MYH11 leukemia.
Oncotarget
; 9(14): 11876-11882, 2018 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545943
7.
Attenuated expression of apoptosis stimulating protein of p53-2 (ASPP2) in human acute leukemia is associated with therapy failure.
PLoS One
; 8(11): e80193, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24312201